The US Supreme Court heard oral arguments in Monsanto v Durnell on April 22, 2026, in a case that could reshape pesticide liability law for chemical applicators, lawn care operators, and homeowners. At issue: whether the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state-law failure-to-warn claims against Bayer (the parent of Monsanto) in the still-running Roundup cancer lawsuits. A decision is expected by the end of the Court’s term in June 2026.
The short version
- SCOTUS heard Monsanto v Durnell oral arguments on April 22, 2026
- Core question: does FIFRA (7 USC 136v) preempt state failure-to-warn claims on EPA-approved labels
- A ruling for Bayer ends most state-court Roundup cancer suits and protects the EPA-approved label as the legal standard
- A ruling for plaintiffs reopens state-law claims and pressures Bayer’s $16B-plus reserve
- Decision expected June 2026 (end of Court term)
- Operators should keep current applicator records and stocked SDS sheets either way
What the case is about
John Durnell is a Missouri groundskeeper who used Roundup for years and was later diagnosed with non-Hodgkin lymphoma. He sued under Missouri state law, arguing that Bayer (through Monsanto) failed to warn that glyphosate could cause cancer. A Missouri jury awarded him a verdict. Bayer appealed, arguing that FIFRA, the federal pesticide statute, preempts any state law that would require a different warning than the EPA-approved label. The EPA has consistently held that glyphosate is not likely to be carcinogenic to humans at label-approved use rates. Bayer’s argument is straightforward: if EPA approved the label and the label does not include a cancer warning, no state can punish the company for following the federal label.
The Missouri Supreme Court ruled against Bayer. SCOTUS granted certiorari in late 2025 and heard oral arguments on April 22, 2026. The docket is at the Supreme Court docket page under case number 23-1068.
Why it matters for operators and applicators
For commercial lawn care operators and certified pesticide applicators, the case has direct economic consequences. If SCOTUS rules for Bayer and finds that FIFRA preempts state failure-to-warn claims, the EPA-approved label becomes the legal ceiling for warnings. Applicators who follow label rates and PPE requirements are insulated from most state product-liability theories tied to label adequacy. That is a meaningful protection for any operator running a five-application annual program.
If SCOTUS rules for the plaintiff and lets the Missouri verdict stand, state-law failure-to-warn claims continue. That means Bayer continues to bleed reserves into Roundup settlements (the company has already set aside more than $16 billion for Roundup litigation), and operators face the secondary question of whether they have any exposure to applicator-stage warning claims. Most applicator liability is shielded by the master applicator (the manufacturer) under FIFRA’s allocation, but a plaintiff-friendly ruling could change that calculus for state-court suits against retailers and applicators in some jurisdictions.
For homeowners, the practical impact is more about product availability than legal exposure. Bayer has already announced it will exit the residential glyphosate market in the US by 2026, replacing consumer Roundup with formulations based on alternative active ingredients. Our coverage of the Bayer Roundup residential exit details the SKU changes homeowners will see at retail.
The legal question, plainly
The federal statute at the center of the case is 7 USC 136v, the preemption provision of FIFRA. It says that states may not impose “any requirements for labeling or packaging in addition to or different from those required” under federal law. Bayer’s argument is that state failure-to-warn claims, by their nature, demand a different label warning. Plaintiffs argue that state common law tort claims are not “requirements for labeling” in the statutory sense, and SCOTUS itself drew a similar line in Bates v Dow AgroSciences in 2005 when it allowed certain state claims to proceed alongside FIFRA-approved labels.
The 2026 Court is more conservative on preemption questions than the 2005 Court, which is part of why plaintiff lawyers and Bayer investors alike see Durnell as a potentially decisive moment. Oral argument transcripts (publicly available on the SCOTUS site) suggested that several justices were skeptical that Bates still governs given the EPA’s repeated reaffirmation of glyphosate safety since 2017.
By the numbers
| Item | Detail |
|---|---|
| Case | Monsanto Company v Durnell, No 23-1068 |
| Oral argument | April 22, 2026 |
| Decision expected | By end of June 2026 |
| Underlying statute | FIFRA, 7 USC 136v |
| Bayer Roundup litigation reserve | $16B-plus |
| EPA glyphosate position | Not likely carcinogenic at label rates |
| IARC glyphosate position (2015) | Probably carcinogenic to humans (Group 2A) |
What operators should do now
Whatever the Court decides, the next 12 months of operational hygiene are the same. Keep your certified applicator records current, including category 3A for ornamental and turf pest control (or your state’s equivalent, like New York’s Category 3A under DEC). Keep Safety Data Sheets stocked for every product on the truck. Document spray-job records (date, applicator, product, EPA registration number, rate, weather conditions) for every commercial job. If you switch to an alternative herbicide while the case is pending, document the why and update your annual program pricing accordingly. Our guide to the Category 3A applicator license walks through the standard documentation set.
On the financial side, operators with large chemical inventories should not pre-buy beyond their next quarter’s program. A ruling for plaintiffs could compress Bayer’s product availability further as the company reallocates legal reserves, and a ruling for Bayer could shift inventory pricing modestly in the other direction. Either way, holding 12 months of glyphosate on the shelf in mid-2026 is not the move.
Background and context
The Roundup litigation has been the largest mass-tort product-liability story in agricultural chemicals in a generation. Bayer acquired Monsanto in 2018 for $63 billion and inherited the Roundup litigation portfolio with it. By 2026, the company had settled tens of thousands of cases, set aside more than $16 billion in legal reserves, and was still trying every available legal theory to cap its exposure. The Durnell case is the third time Bayer has sought SCOTUS review on the FIFRA preemption question. SCOTUS declined to hear earlier petitions (most notably Hardeman in 2022). It granted Durnell in late 2025 because the Missouri ruling created a clearer circuit split.
For the EPA side of the story, the agency’s parallel glyphosate registration review is expected to issue its final decision in October 2026. That review will fold in new spray-drift label requirements and herbicide-resistance language but is not expected to change the agency’s underlying not-likely-carcinogenic finding.
FAQ
When will SCOTUS rule on Monsanto v Durnell?
A decision is expected by the end of the Supreme Court’s current term, which runs to late June 2026.
Does this case affect homeowner Roundup use?
Indirectly. Bayer is already exiting the residential glyphosate market in 2026 regardless of the ruling. A ruling for Bayer could change the speed of the rollout for replacement consumer SKUs. A ruling for plaintiffs likely accelerates the residential exit.
Are commercial applicators personally liable?
Under current law, applicators who follow the EPA-approved label, rate, PPE, and posting requirements have a strong defense. Most failure-to-warn liability sits with the manufacturer. A plaintiff-friendly Durnell ruling could open new state-law theories in some jurisdictions, but the practical exposure for a documented commercial applicator remains low.
What is FIFRA preemption?
FIFRA preemption is the legal doctrine that federal pesticide-labeling law (specifically 7 USC 136v) blocks states from imposing different or additional labeling requirements. The scope of that preemption is the central question in Durnell.
Bottom line
Monsanto v Durnell is the most consequential pesticide-liability case to reach SCOTUS in two decades. A ruling for Bayer locks in the EPA-approved label as the legal ceiling and protects commercial applicators from most state failure-to-warn theories. A ruling for plaintiffs keeps Bayer’s reserves bleeding and could nudge alternative active ingredients into market share faster than already planned. Operators should not pre-buy chemical inventory in anticipation of either outcome. Keep records current, watch for the June ruling, and price annual programs accordingly.